Bimeda-MTC Animal Health Inc. — licence 100306, currently licensed, last inspection rating NC (2026-03-02).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02457180 | BANAMINE | INTERVET CANADA CORP | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 00465305 | BANAMINE | INTERVET CANADA CORP | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02563584 | FLUTREXIN | MODERN VETERINARY THERAPEUTICS LLC | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02550474 | SOLNIXON | BIMEDA-MTC ANIMAL HEALTH INC | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02234061 | SOLVEZINE | NORBROOK LABORATORIES LTD. | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 00465291 | BANAMINE GRANULES | SCHERING-PLOUGH CANADA INC | Granules | FLUNIXIN (FLUNIXIN MEGLUMINE) 25 MG | Cancelled Post Market |
| 02231381 | CITATION INJECTION | BAYER INC., ANIMAL HEALTH | Liquid | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02230652 | CRONYXIN INJECTION | CROSS VETPHARM GROUP LTD | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02239149 | INFLUX-50 (FLUNIXIN MEGLUMINE INJECTION) STERILE INJECTABLE SOLUTION | VETOQUINOL N A INC | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02248807 | SUPPRESSOR | NORBROOK LABORATORIES LTD. | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02478951 | VETONIXIN | NORBROOK LABORATORIES LTD. | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Dormant |
| NOC | Date | Submission | Reason |
|---|
| 18308 | 2016-07-28 | Supplement to an Abbreviated New Drug Submission (SANDS) | NEW SPECIES (SWINE) AND ASSOCIATED INDICATION |
| 11060 | 2010-02-19 | Supplement to an Abbreviated New Drug Submission (SANDS) | Additional indication |
| 9428 | 2008-03-19 | Supplement to an Abbreviated New Drug Submission (SANDS) | FOR THE CONTROL OF PYREXIA ASSOCIATED WITH BOVINE RESPIRATORY DISEASE, AND THE CONTROL OF PYREXIA AND INFLAMMATION ASSOCIATED WITH ENDOTOXEMIA, IN BEEF CATTLE AND NON-LACTATING DAIRY CATTLE; ALTERNATE SOURCE OF ACTIVE INGREDIENT |
| 6244 | 2001-04-02 | New Drug Submission (NDS) | |
| 6534 | 1999-07-06 | New Drug Submission (NDS) | |